Market Cap ₹5382 Cr.
Stock P/E 86.0
P/B 3.1
Current Price ₹865.5
Book Value ₹ 280
Face Value 2
52W High ₹1030
Dividend Yield 0%
52W Low ₹ 389.2
VA Tech Wabag Ltd is a holding enterprise engaged in water treatment area. The Company's primary activities consist of design, supply, construction, installation and operational management of drinking water, waste water remedy, industrial water remedy and desalination plants. The Company's segments include both inside and ouside of India. Its product portfolio consists of water reclamation, municipal used water treatment, industrial effluent treatment, anaerobic sludge remedy, and industrial water reuse and recycling. The Company has 4 clusters: India, Europe, Middle East & Africa (MEA), and Latin America (LATAM). The India cluster provides end-to-end water solutions for drinking water and wastewater plants, each in the municipal and industrial sectors. The European cluster caters to small and mid-sized tasks. The MEA cluster has 2 principal regions: the Middle East and Africa. The LATAM cluster has countries, which include Brazil, Chile, Colombia, Ecuador, Mexico and Peru.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 684 | 745 | 892 | 632 | 750 | 652 | 927 | 553 | 665 | 704 |
Other Income | 3 | 5 | 10 | 33 | 23 | 2 | 8 | 26 | 15 | 4 |
Total Income | 687 | 751 | 902 | 665 | 773 | 654 | 935 | 579 | 680 | 708 |
Total Expenditure | 627 | 669 | 820 | 601 | 676 | 560 | 818 | 487 | 579 | 606 |
Operating Profit | 60 | 82 | 81 | 64 | 97 | 94 | 116 | 91 | 102 | 103 |
Interest | 22 | 22 | 24 | 16 | 17 | 16 | 16 | 16 | 17 | 17 |
Depreciation | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | -8 | -21 | -17 | -243 | 0 | 0 | 0 |
Profit Before Tax | 35 | 57 | 55 | 37 | 57 | 58 | -146 | 74 | 83 | 84 |
Provision for Tax | 9 | 11 | 10 | 9 | 13 | 13 | -30 | 14 | 23 | 21 |
Profit After Tax | 26 | 46 | 45 | 28 | 44 | 45 | -116 | 59 | 60 | 63 |
Adjustments | 1 | -2 | 2 | 2 | 3 | 2 | 5 | -9 | 0 | -0 |
Profit After Adjustments | 26 | 44 | 46 | 30 | 47 | 47 | -111 | 50 | 60 | 63 |
Adjusted Earnings Per Share | 4.2 | 7.1 | 7.4 | 4.9 | 7.5 | 7.6 | -17.9 | 8.1 | 9.7 | 10.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1619 | 2239 | 2435 | 2508 | 3208 | 3457 | 2781 | 2557 | 2834 | 2979 | 2960 | 2849 |
Other Income | 13 | 13 | 8 | 44 | 12 | 6 | 17 | 35 | 9 | 33 | 54 | 53 |
Total Income | 1632 | 2251 | 2443 | 2552 | 3219 | 3463 | 2798 | 2592 | 2844 | 3013 | 3014 | 2902 |
Total Expenditure | 1465 | 2050 | 2226 | 2311 | 2912 | 3166 | 2600 | 2340 | 2617 | 2743 | 2643 | 2490 |
Operating Profit | 167 | 201 | 217 | 241 | 308 | 297 | 198 | 252 | 227 | 269 | 371 | 412 |
Interest | 21 | 25 | 39 | 46 | 53 | 58 | 75 | 109 | 90 | 88 | 66 | 66 |
Depreciation | 11 | 15 | 11 | 20 | 19 | 18 | 17 | 15 | 12 | 10 | 9 | 8 |
Exceptional Income / Expenses | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -289 | -243 |
Profit Before Tax | 135 | 166 | 167 | 157 | 179 | 224 | 110 | 132 | 130 | 168 | 17 | 95 |
Provision for Tax | 46 | 53 | 57 | 67 | 67 | 77 | 20 | 49 | 29 | 36 | 6 | 28 |
Profit After Tax | 90 | 114 | 110 | 90 | 112 | 147 | 89 | 84 | 101 | 132 | 11 | 66 |
Adjustments | 1 | -0 | -0 | -2 | -10 | -16 | 16 | 7 | 9 | -0 | 2 | -4 |
Profit After Adjustments | 90 | 113 | 110 | 89 | 102 | 132 | 105 | 91 | 110 | 132 | 13 | 62 |
Adjusted Earnings Per Share | 17 | 21.3 | 20.3 | 16.3 | 18.8 | 24.1 | 19.2 | 16.6 | 17.7 | 21.2 | 2.1 | 10 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -1% | 5% | -3% | 6% |
Operating Profit CAGR | 38% | 14% | 5% | 8% |
PAT CAGR | -92% | -49% | -40% | -19% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 106% | 48% | 26% | 8% |
ROE Average | 1% | 6% | 7% | 10% |
ROCE Average | 4% | 10% | 11% | 16% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 715 | 841 | 903 | 920 | 993 | 1129 | 1069 | 1174 | 1410 | 1539 | 1575 |
Minority's Interest | 2 | 3 | 5 | 8 | 17 | 34 | 17 | -2 | -13 | -13 | -0 |
Borrowings | 3 | 45 | 69 | 50 | 63 | 50 | 100 | 30 | 132 | 94 | 55 |
Other Non-Current Liabilities | 101 | 376 | 219 | 147 | 182 | 185 | 75 | 212 | 238 | 177 | 122 |
Total Current Liabilities | 1212 | 1569 | 1349 | 1771 | 2071 | 2295 | 2420 | 2585 | 2365 | 2169 | 2242 |
Total Liabilities | 2033 | 2834 | 2545 | 2897 | 3326 | 3692 | 3679 | 3999 | 4132 | 3966 | 4052 |
Fixed Assets | 51 | 119 | 191 | 175 | 174 | 172 | 149 | 86 | 86 | 80 | 75 |
Other Non-Current Assets | 188 | 475 | 254 | 377 | 451 | 500 | 440 | 582 | 741 | 922 | 905 |
Total Current Assets | 1794 | 2239 | 2099 | 2345 | 2700 | 3020 | 3090 | 3331 | 3305 | 2964 | 2989 |
Total Assets | 2033 | 2834 | 2545 | 2897 | 3326 | 3692 | 3679 | 3999 | 4132 | 3966 | 4052 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 265 | 244 | 330 | 221 | 273 | 231 | 133 | 118 | 249 | 300 | 321 |
Cash Flow from Operating Activities | 82 | 112 | 6 | -217 | 6 | -216 | -76 | 245 | 135 | 12 | 85 |
Cash Flow from Investing Activities | -40 | -97 | -68 | 97 | 61 | -11 | 11 | 30 | -4 | -34 | 16 |
Cash Flow from Financing Activities | -65 | 48 | 2 | 182 | -100 | 106 | 49 | -135 | -86 | 45 | -240 |
Net Cash Inflow / Outflow | -24 | 63 | -60 | 61 | -33 | -120 | -17 | 139 | 45 | 22 | -139 |
Closing Cash & Cash Equivalent | 244 | 330 | 240 | 307 | 231 | 133 | 118 | 249 | 300 | 321 | 207 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 17.01 | 21.31 | 20.28 | 16.28 | 18.77 | 24.06 | 19.2 | 16.63 | 17.7 | 21.21 | 2.07 |
CEPS(Rs) | 18.93 | 24.18 | 22.35 | 20.33 | 24.08 | 30.17 | 19.38 | 18.16 | 18.16 | 22.86 | 3.17 |
DPS(Rs) | 7 | 8 | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 134.7 | 157.83 | 166.08 | 168.75 | 181.95 | 206.46 | 195.41 | 214.71 | 226.65 | 247.45 | 253.2 |
Core EBITDA Margin(%) | 9.51 | 8.42 | 8.6 | 7.86 | 9.24 | 8.44 | 6.51 | 8.48 | 7.69 | 7.92 | 10.73 |
EBIT Margin(%) | 9.66 | 8.55 | 8.47 | 8.09 | 7.22 | 8.16 | 6.65 | 9.44 | 7.78 | 8.6 | 2.79 |
Pre Tax Margin(%) | 8.35 | 7.42 | 6.86 | 6.26 | 5.58 | 6.49 | 3.95 | 5.18 | 4.6 | 5.65 | 0.57 |
PAT Margin (%) | 5.53 | 5.08 | 4.54 | 3.6 | 3.5 | 4.25 | 3.21 | 3.28 | 3.56 | 4.43 | 0.37 |
Cash Profit Margin (%) | 6.21 | 5.75 | 4.98 | 4.42 | 4.09 | 4.77 | 3.81 | 3.88 | 3.98 | 4.77 | 0.67 |
ROA(%) | 4.59 | 4.67 | 4.11 | 3.32 | 3.61 | 4.19 | 2.42 | 2.19 | 2.48 | 3.26 | 0.27 |
ROE(%) | 13.2 | 14.61 | 12.69 | 9.92 | 11.74 | 13.87 | 8.12 | 7.48 | 7.8 | 8.96 | 0.7 |
ROCE(%) | 19.99 | 21.3 | 19.81 | 16.96 | 17.7 | 19.34 | 11.24 | 14.31 | 12.78 | 13.74 | 4.4 |
Receivable days | 248.25 | 203.56 | 214.95 | 228.26 | 215.06 | 180.88 | 174.16 | 209.85 | 189.23 | 163.87 | 174.6 |
Inventory Days | 10.19 | 6.16 | 6.15 | 10.52 | 7.74 | 4.05 | 3.52 | 2.98 | 3.62 | 3.78 | 4.51 |
Payable days | 272.49 | 219.29 | 418.66 | 390.32 | 343 | 386.2 | 530.68 | 609.05 | 467.78 | 335.46 | 299.57 |
PER(x) | 14.69 | 18.53 | 40.48 | 31.94 | 36.04 | 20.61 | 17.27 | 4.98 | 14.16 | 13.22 | 170.46 |
Price/Book(x) | 1.86 | 2.5 | 4.94 | 3.08 | 3.72 | 2.4 | 1.7 | 0.39 | 1.11 | 1.13 | 1.39 |
Dividend Yield(%) | 1.4 | 1.01 | 0.49 | 0.77 | 0.59 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.69 | 0.84 | 1.78 | 1.14 | 1.17 | 0.87 | 0.81 | 0.25 | 0.54 | 0.59 | 0.72 |
EV/Core EBITDA(x) | 6.71 | 9.38 | 19.92 | 11.87 | 12.16 | 10.11 | 11.33 | 2.58 | 6.77 | 6.48 | 5.73 |
Net Sales Growth(%) | 12.15 | 38.28 | 8.78 | 3 | 27.89 | 7.77 | -19.56 | -8.05 | 10.85 | 5.11 | -0.63 |
EBIT Growth(%) | 14.53 | 22.43 | 7.79 | -1.69 | 14.12 | -2.29 | -34.42 | 30.52 | -8.66 | 19.2 | -67.73 |
PAT Growth(%) | 22.52 | 26.81 | -2.78 | -18.25 | 24.3 | -13.24 | -39.33 | -5.93 | 20.12 | 38.91 | -91.72 |
EPS Growth(%) | 22.26 | 25.23 | -4.84 | -19.71 | 15.3 | 28.19 | -20.22 | -13.39 | 6.45 | 19.81 | -90.26 |
Debt/Equity(x) | 0.11 | 0.19 | 0.2 | 0.42 | 0.32 | 0.43 | 0.57 | 0.44 | 0.25 | 0.28 | 0.14 |
Current Ratio(x) | 1.48 | 1.43 | 1.56 | 1.32 | 1.3 | 1.32 | 1.28 | 1.29 | 1.4 | 1.37 | 1.33 |
Quick Ratio(x) | 1.45 | 1.4 | 1.52 | 1.27 | 1.29 | 1.3 | 1.27 | 1.28 | 1.38 | 1.35 | 1.31 |
Interest Cover(x) | 7.39 | 7.59 | 5.26 | 4.43 | 4.4 | 4.89 | 2.46 | 2.22 | 2.44 | 2.92 | 1.26 |
Total Debt/Mcap(x) | 0.06 | 0.08 | 0.04 | 0.14 | 0.08 | 0.18 | 0.34 | 1.15 | 0.22 | 0.25 | 0.1 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 21.7 | 21.7 | 21.7 | 19.13 | 19.13 | 19.13 | 19.13 | 19.13 | 19.13 | 19.13 |
FII | 18.04 | 16.17 | 15.35 | 14.42 | 15.94 | 16.57 | 16.67 | 15.64 | 13.1 | 12.45 |
DII | 3.62 | 3.62 | 3.28 | 3.25 | 3.45 | 3.25 | 3.55 | 3.53 | 5.85 | 5.63 |
Public | 56.64 | 58.51 | 59.68 | 63.2 | 61.47 | 61.06 | 60.65 | 61.71 | 61.92 | 62.8 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.35 | 1.35 | 1.35 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 |
FII | 1.12 | 1.01 | 0.95 | 0.9 | 0.99 | 1.03 | 1.04 | 0.97 | 0.81 | 0.77 |
DII | 0.23 | 0.23 | 0.2 | 0.2 | 0.21 | 0.2 | 0.22 | 0.22 | 0.36 | 0.35 |
Public | 3.52 | 3.64 | 3.71 | 3.93 | 3.82 | 3.8 | 3.77 | 3.84 | 3.85 | 3.91 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 | 6.22 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About